| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |